Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
about
Drugs for preventing malaria in travellersDrugs for preventing malaria in travellersThe evolution of tafenoquine--antimalarial for a new millennium?Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEuropPrimaquine in vivax malaria: an update and review on management issuesReview: Malaria chemoprophylaxis for travelers to Latin AmericaKilling the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivaxA new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malariaSuppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malariaMalaria Distribution, Prevalence, Drug Resistance and Control in IndonesiaRandomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.Resistance to therapies for infection by Plasmodium vivaxProphylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).Endemic infectious diseases of Afghanistan.Lymphocyte proliferative response and subset profiles during extended periods of chloroquine or primaquine prophylaxis.Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of ageChloroquine resistance in Plasmodium vivax.Prophylaxis of malaria.An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in CambodiaVitamin D as Supplemental Therapy for Pneumocystis Pneumonia.Survey of resistance to chloroquine by Plasmodium vivax in Indonesia.Assessment of safety of the major antimalarial drugs.Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.Malaria, mefloquine and oil-workers.Fever after a stay in the tropics. Part 2: Common imported tropical diseases.The practice of travel medicine: guidelines by the Infectious Diseases Society of America.Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: the case for expanded use of primaquine as a causal prophylactic.Malaria and Travellers
P2860
Q21032525-C974568C-EA1D-4E28-89E3-5FA6AABF0E3DQ24186690-A9A3C535-408A-40D3-83BB-5BD17BE65AA8Q24536171-73A04C5E-8031-44BD-A549-64A6CB8F752DQ24804103-E18573ED-07F8-4427-8DAB-86E1C8D6930CQ27003856-14BC1257-B506-4672-A651-1F2CA988E844Q27025288-6D564FDE-B3A5-4EFC-A7AC-9B7CC95F4048Q28081463-980AAD8F-49CE-4ADE-9738-FA0EE262DBD3Q28204425-E680DEDA-507B-40BB-A46C-0264FC3D3CECQ28488306-6397DD6E-9B11-4486-B932-0D0F6C80BF6FQ29306432-E67703C2-1737-4D29-884F-A19103868FB9Q30847884-509821F7-ED42-495F-A675-E89F7DEAC317Q30994453-885A6B63-CF63-4243-9EDE-4311A3917D43Q31030931-EDFC86E6-778F-496D-8866-E728B813A050Q33481576-B27490CA-EB5F-4930-8843-5C347B8C2CD8Q33696465-A4F94333-6F10-4066-8E8E-1BEA7C3FA5E9Q34597830-3EA1B022-47E1-480F-A062-A1ED06DC7419Q34645383-DA4AA4BA-F972-4292-9F10-9C4216207943Q35129889-BCFAF1DE-5200-44E6-AD28-DF069D04C819Q35867507-DA1D59E9-E7D7-472B-90F6-0CA04EE99C3EQ35927662-26F37083-5658-477A-B1B1-6D1C06DFD815Q36091888-23CBEBF8-F109-4503-88B0-AD6542C91383Q36175374-962F4C93-9619-4B37-882B-238E8CBC4178Q36644639-AAEEBE0D-CFAC-4CC0-9580-4BB8F4278D18Q36828336-14734A8D-CA1E-45C0-A637-F38AC791C531Q36945007-9ACB9884-4523-474B-BB1E-4A01374270AAQ38603812-D74E517E-91B6-42CC-A5A9-AD27EDF069D4Q38893657-6E6E87D8-3D37-4D35-A562-CDD5B18B4BF7Q38916168-13427459-58A6-4D3A-A2D3-4805A6E8DDC5Q39067681-6CEBBD16-4017-4017-A59B-60D96E4DF56BQ40092648-F800B941-9BAB-450B-9699-3F3781E19175Q41925324-F95F2C72-CE47-4B1A-9483-47FB39F2C4A2Q46905862-20505FD2-ED2B-4029-BD7E-B49CCC480B14Q58214241-EBA5AD5A-CB72-4A51-8BF2-E5A0B68657D5
P2860
Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Randomised placebo-controlled ...... falciparum and vivax malaria.
@ast
Randomised placebo-controlled ...... falciparum and vivax malaria.
@en
Randomised placebo-controlled ...... falciparum and vivax malaria.
@nl
type
label
Randomised placebo-controlled ...... falciparum and vivax malaria.
@ast
Randomised placebo-controlled ...... falciparum and vivax malaria.
@en
Randomised placebo-controlled ...... falciparum and vivax malaria.
@nl
prefLabel
Randomised placebo-controlled ...... falciparum and vivax malaria.
@ast
Randomised placebo-controlled ...... falciparum and vivax malaria.
@en
Randomised placebo-controlled ...... falciparum and vivax malaria.
@nl
P2093
P921
P1433
P1476
Randomised placebo-controlled ...... f falciparum and vivax malaria
@en
P2093
A L Richards
C J Church
D J Fryauff
I Sumawinata
P304
P356
10.1016/S0140-6736(95)92898-7
P407
P577
1995-11-01T00:00:00Z